12:14 PM EST - Emerald Health Therapeutics Inc. : Through Emerald Health Botanicals Inc., its wholly owned subsidiary and a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations, has submitted license applications to Health Canada for approval of two new growing sites. Emerald is preparing for the large-scale production of cannabis in anticipation of legalization of the adult-use cannabis market on July 1, 2018. Emerald Health Therapeutics Inc.
shares V.EMH are trading up $0.02 at $1.41.
